Avalo Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 11/14/2025 | 1.36 M | $17.23 M | 31.83% | 9.68% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.35 M | $17.15 M | 39.53% | 9.64% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 1.24 M | $15.70 M | 24.12% | 8.82% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.05 M | $13.40 M | 100.00% | 7.53% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 1.01 M | $12.79 M | 65.53% | 7.19% |
| CALIGAN PARTNERS LP | 11/14/2025 | 833.33 K | $10.59 M | 100.00% | 5.95% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2025 | 817.44 K | $10.39 M | 100.00% | 5.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 720.92 K | $9.16 M | 100.00% | 5.15% |
| VANGUARD GROUP INC | 11/07/2025 | 692.64 K | $8.80 M | 314.90% | 4.95% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 662.97 K | $8.43 M | -28.94% | 4.74% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 605.84 K | $7.70 M | 49.01% | 4.33% |
| COMMODORE CAPITAL LP | 11/14/2025 | 483.00 K | $6.14 M | 0.00% | 3.45% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/17/2025 | 483.00 K | $6.14 M | 0.00% | 3.45% |
| CITADEL ADVISORS LLC | 11/14/2025 | 481.67 K | $6.12 M | 100.00% | 3.44% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 11/14/2025 | 263.64 K | $3.35 M | 70.12% | 1.88% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 258.77 K | $3.29 M | 100.00% | 1.85% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2025 | 228.30 K | $2.90 M | 1,916.58% | 1.63% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 213.57 K | $2.71 M | 100.00% | 1.53% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2025 | 188.08 K | $2.39 M | 100.00% | 1.34% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2025 | 178.10 K | $2.26 M | 100.00% | 1.27% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 159.78 K | $2.03 M | 352.63% | 1.14% |
| BLACKROCK, INC. | 11/12/2025 | 154.25 K | $1.96 M | -1.06% | 1.10% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 144.60 K | $1.84 M | -74.50% | 1.03% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 139.67 K | $1.78 M | 0.00% | 1.00% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 137.43 K | $1.75 M | 100.00% | 0.98% |
| BOXER CAPITAL MANAGEMENT, LLC | 11/14/2025 | 125.00 K | $1.59 M | 100.00% | 0.89% |
| CANTOR FITZGERALD, L. P. | 12/01/2025 | 85.25 K | $1.08 M | 100.00% | 0.79% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 104.19 K | $1.33 M | -5.68% | 0.74% |
| EXOME ASSET MANAGEMENT LLC | 11/14/2025 | 100.04 K | $1.27 M | 100.00% | 0.71% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 100.00 K | $1.27 M | 100.00% | 0.71% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2025 | 98.70 K | $1.25 M | 100.00% | 0.71% |
| ADVISER INVESTMENTS LLC | 11/10/2025 | 86.52 K | $1.10 M | -66.85% | 0.62% |
| DLD ASSET MANAGEMENT, LP | 11/14/2025 | 75.00 K | $953.25 K | 100.00% | 0.54% |
| ABRDN PLC | 11/07/2025 | 72.80 K | $925.29 K | 100.00% | 0.52% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 72.17 K | $917.32 K | 0.00% | 0.52% |
| MARSHALL WACE, LLP | 11/13/2025 | 56.01 K | $711.87 K | 100.00% | 0.40% |
| QUADRATURE CAPITAL LTD | 11/13/2025 | 55.00 K | $695.74 K | 401.08% | 0.39% |
| DLD ASSET MANAGEMENT, LP | 11/14/2025 | 53.10 K | $673.04 K | 100.00% | 0.38% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 50.70 K | $644.40 K | 100.00% | 0.36% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 49.24 K | $625.87 K | 282.05% | 0.35% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 47.40 K | $602.43 K | 100.00% | 0.34% |
| STATE STREET CORP | 11/14/2025 | 45.45 K | $577.72 K | 100.00% | 0.32% |
| UBS GROUP AG | 11/13/2025 | 45.21 K | $574.59 K | -46.00% | 0.32% |
| WALLEYE CAPITAL LLC | 11/14/2025 | 44.74 K | $568.68 K | 117.06% | 0.32% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 11/13/2025 | 33.34 K | $423.71 K | 100.00% | 0.24% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 32.39 K | $411.72 K | -69.07% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 11/13/2025 | 31.00 K | $394.01 K | 100.00% | 0.22% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 27.78 K | $353.06 K | 100.00% | 0.20% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 11/14/2025 | 24.63 K | $313.02 K | 100.00% | 0.18% |
| DLD ASSET MANAGEMENT, LP | 11/14/2025 | 23.40 K | $296.60 K | 100.00% | 0.17% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avalo Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of Avalo Therapeutics, Inc.. The most heavily invested institutionals were:
BVF INC/IL: 1.36 M
ORBIMED ADVISORS LLC: 1.35 M
Nantahala Capital Management, LLC: 1.24 M
Point72 Asset Management, L.P.: 1.05 M
Affinity Asset Advisors, LLC: 1.01 M
Caligan Partners LP: 833,333
141.44% of Avalo Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 15.37 M shares in the last 24 months. This purchase volume represents approximately $205.98 M in transactions.